British American Tobacco plc

Revenue comes overwhelmingly from selling manufactured tobacco and nicotine products outright, with control and payment passing to the buyer at the point of delivery rather than through subscriptions or usage fees. Several margin and cash-flow measures, spanning gross, operating, net and cash-conversion levels, sit toward the upper end of their peer ranges, and free cash flow is elevated relative to assets, equity and operating cash flow alike. At the same time, reported net income turned negative in at least one recent year even while these cash and margin patterns held, showing that reported earnings and cash generation do not always move together for this company.

As a business built around converting raw material into product at fixed-rate factories, its capacity to grow output is tied to how many plants it runs and how fast each one can convert input into finished product, and its own account ties further growth in its newer nicotine categories specifically to whether outside suppliers can scale alongside it. CompanyGraph maps a substantial group of other companies as running this same kind of fixed-capacity conversion system, so this way of scaling is not unique to it. Separately, a large share of its assets sits in intangible and goodwill items rather than physical plant, and goodwill is large relative to shareholders' equity too, which together point to scale built partly through acquiring existing brands and businesses rather than through organic capacity build-out alone.

Its own account names the physical inputs it depends on: tobacco leaf grown by a large base of contracted farmers and third-party suppliers, plus wood pulp and energy, with some leaf purchased through its Indian associate, ITC, partly via auctions. It also relies on outside manufacturers for part of its newer nicotine product lines, and its own risk disclosures point to dependence on suppliers able to scale that newer production, on single suppliers at some points in that chain, and on outside partners for design and adequate component supply. CompanyGraph's mapping also places it midway along its supply chain, connected both upstream to suppliers and downstream to customers.

Its own account describes a broad customer base rather than a concentrated one: buyers range from large retail corporations down to small independent shop owners, with key customers clustered in grocery, convenience and petrol-station convenience channels who in turn sell to adult consumers. CompanyGraph's mapping places the company midway along its supply chain, connected downstream to a customer base as well as upstream to suppliers, though the evidence here does not show how concentrated that downstream base is in revenue terms.

Among the group of companies CompanyGraph treats as its industry peers, most are set up to move goods that others make, while this one is set up to make the product itself, which is an uncommon position within that group. Its own account also points to a wide portfolio of long-established brand names and a balance sheet weighted heavily toward intangible and goodwill assets, indicating that a large part of what distinguishes it sits in accumulated brand equity rather than in physical assets alone. Nothing on file measures whether competitors are able or unable to copy either position, so only the position itself, not its defensibility, is described here.

Businesses that convert raw material into finished product at fixed-rate factories are typically bound by how much of that installed capacity they can run and keep fed with input material, and tend to fail at this if they cannot be supplied or run at rate. That is a general pattern for this category of business, not something measured specifically for this company. Its own account speaks to a narrower version of it: for its newer nicotine categories specifically, it names supplier capacity to scale production, single-source dependencies at points in that supply chain, and adequate consumables capacity as factors that could limit growth, alongside regulatory approval and the availability of skilled talent and raw materials more broadly. It does not describe the group as a whole as either demand-constrained or supply-constrained.

Its own filing names illicit, untaxed trade in its own product category as the first specific risk under its broader business-execution and supply-chain risk heading, describing it as a significant and growing threat to the legitimate industry it operates in, including its newer nicotine categories. Within that same disclosure, it also flags concentrated production sites and distributors that control large geographic territories, and single-supplier dependencies at specific points in the supply chain for its newer nicotine products, as sources of risk to its own operations.

Its own risk disclosures open with business-execution and supply-chain risk, and the first specific threat they name is competition from illicit, untaxed trade in its own product category. Its own account also describes regulatory clearance requirements before health-related claims can be made for specific vapour, heated and oral nicotine products, ongoing product-liability litigation tied to smoking and health, and exposure to sanctions, tariffs and trade embargoes, including operations in Cuba, which is subject to United States sanctions, and a past settlement with US authorities over a sanctions breach connected to North Korea. It also names exposure to swings across a wide range of foreign currencies in which it earns revenue and holds assets.